Founder, Director and Chief Technology Officer
Cerinfuse Technologies, Inc.
Michael A. Vogelbaum, MD, PhD, is the former Program Leader of NeuroOncology and Chief of Neurosurgery at Moffitt Cancer Center, and prior to that he was the Associate Director of the Cleveland Clinic Brain Tumor and NeuroOncology Center. Dr. Vogelbaum has had an externally funded basic science and translational research program which focused on immunobiology of brain tumors, Phase 0/Window of Opportunity clinical trials, and trials that involved active delivery of therapeutic agents to the brain. He is currently developing novel devices for delivering therapeutics directly to the brain, for which he has received multiple patents. One of his past devices has been used in clinical trials and it has received a 510(k) clearance from the FDA. He is the Founder and Chief Medical Officer of Cerinfuse Technologies, Inc., which is commercializing a new suite oftherapeutic delivery devices that he has invented. Dr. Vogelbaum was a co-founder of the Response Assessment in NeuroOncology (RANO) group, Chair of the Neurosurgery Committee for NRG Oncology, and he has been a Vice President of the Society for NeuroOncology (SNO).
Disclosure(s): Cerinfuse Technologies, Inc.: Board Member/Officer/Trustee (Ongoing), Ownership or Partnership (Ongoing)
Sunday, May 3, 2026
2:25 PM - 2:45 PM CT